Cantel Medical Corp. (NYSE: CMD)

Rowley Law PLLC is investigating potential securities law violations by Cantel Medical Corporation (NYSE: CMD) (“Cantel”) and its board of directors concerning the proposed acquisition of the company by Steris Plc (NYSE: STE) (“Steris”). Under the terms of the agreement, Cantel common stockholders will receive approximately $16.93 in cash and 0.33787 of a Steris ordinary share, or a total of value of approximately $84.66 per Cantel common share based on Steris’s closing share price of $200.46 on January 11, 2021. The transaction is valued at approximately $4.6 billion and is expected to close by June 30, 2021.

If you are a stockholder of Cantel and are interested in obtaining additional information regarding this investigation, please fill in the contact form on this page. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.